title: Platelet activation in ovines undergoing sham surgery or implant of the second generation PediaFlow pediatric ventricular assist device.
abstract: The PediaFlow pediatric ventricular assist device (VAD) is a magnetically levitated turbodynamic pump under development for circulatory support of small children with a targeted flow rate range of 0.3-1.5 L/min. As the design of this device is refined, ensuring high levels of blood biocompatibility is essential. In this study, we characterized platelet activation during the implantation and operation of a second generation prototype of the PediaFlow VAD (PF2) and also performed a series of surgical sham studies to examine purely surgical effects on platelet activation. In addition, a newly available monoclonal antibody was characterized and shown to be capable of quantifying ovine platelet activation. The PF2 was implanted in three chronic ovine experiments of 17, 30, and 70 days, while surgical sham procedures were performed in five ovines with 30-day monitoring. Blood biocompatibility in terms of circulating activated platelets was measured by flow cytometric assays with and without exogenous agonist stimulation. Platelet activation following sham surgery returned to baseline in approximately 2 weeks. Platelets in PF2-implanted ovines returned to baseline activation levels in all three animals and showed an ability to respond to agonist stimulation. Late-term platelet activation was observed in one animal corresponding with unexpected pump stoppages related to a manufacturing defect in the percutaneous cable. The results demonstrated encouraging platelet biocompatibility for the PF2 in that basal platelet activation was achieved early in the pump implant period. Furthermore, this first characterization of the effect of a major cardiothoracic procedure on temporal ovine platelet activation provides comparative data for future cardiovascular device evaluation in the ovine model.
authors.affiliation: Department of Bioengineering, University of Pittsburgh McGowan Institute for Regenerative Medicine, University of Pittsburgh Cardiothoracic Surgery, Children's Hospital of Pittsburgh Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA.
authors.forename: Carl A
authors.initials: CA
authors.lastname: Johnson
authors.forename: Peter D
authors.initials: PD
authors.lastname: Wearden
authors.forename: Ergin
authors.initials: E
authors.lastname: Kocyildirim
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Maul
authors.forename: Joshua R
authors.initials: JR
authors.lastname: Woolley
authors.forename: Sang-Ho
authors.initials: SH
authors.lastname: Ye
authors.forename: Elise M
authors.initials: EM
authors.lastname: Strickler
authors.forename: Harvey S
authors.initials: HS
authors.lastname: Borovetz
authors.forename: William R
authors.initials: WR
authors.lastname: Wagner
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000378:metabolism*; D002648:Child; D004867:Equipment Design; D006353:Heart-Assist Devices; D006801:Humans; D008422:Materials Testing; D015539:Platelet Activation; D019919:Prosthesis Implantation; D012756:Sheep
chemical_list: D001672:Biocompatible Materials